[go: up one dir, main page]

ATE306911T1 - Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten - Google Patents

Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten

Info

Publication number
ATE306911T1
ATE306911T1 AT99934397T AT99934397T ATE306911T1 AT E306911 T1 ATE306911 T1 AT E306911T1 AT 99934397 T AT99934397 T AT 99934397T AT 99934397 T AT99934397 T AT 99934397T AT E306911 T1 ATE306911 T1 AT E306911T1
Authority
AT
Austria
Prior art keywords
compositions
detecting
mycobacterial diseases
diagnosing infectious
methods
Prior art date
Application number
AT99934397T
Other languages
English (en)
Inventor
Reiko M Nakamura
Original Assignee
Japan Bcg Lab
Reiko M Nakamura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Bcg Lab, Reiko M Nakamura filed Critical Japan Bcg Lab
Application granted granted Critical
Publication of ATE306911T1 publication Critical patent/ATE306911T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT99934397T 1998-02-06 1999-02-04 Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten ATE306911T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7391198P 1998-02-06 1998-02-06
US9614098P 1998-08-11 1998-08-11
PCT/IB1999/000215 WO1999039693A2 (en) 1998-02-06 1999-02-04 Methods and compositions for detection and diagnosis of infectious diseases

Publications (1)

Publication Number Publication Date
ATE306911T1 true ATE306911T1 (de) 2005-11-15

Family

ID=26755032

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99934397T ATE306911T1 (de) 1998-02-06 1999-02-04 Zusammensetzungen zum nachweis und zur diagnose von infektiösen mykobakteriellen krankheiten

Country Status (10)

Country Link
US (3) US6979450B2 (de)
EP (1) EP1061905B1 (de)
JP (1) JP4323600B2 (de)
CN (3) CN1194670C (de)
AT (1) ATE306911T1 (de)
AU (1) AU4480899A (de)
CA (1) CA2319571C (de)
DE (1) DE69927794T2 (de)
HK (2) HK1035141A1 (de)
WO (1) WO1999039693A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1194670C (zh) * 1998-02-06 2005-03-30 日本Bcg制造株式会社 用于传染病检测和诊断的方法和组合物
CN1656211B (zh) * 2002-05-21 2010-04-28 爱科来株式会社 抗酸细菌的溶菌方法和用其进行基因扩增或检测的方法
WO2007130846A2 (en) * 2006-05-03 2007-11-15 Pritest, Inc. Improved compositions and methods of testing for tuberculosis and mycobacterium infection
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.
EP2595617B1 (de) * 2010-07-19 2016-12-07 Arcion Therapeutics, Inc. Topische behandlung von neuropathischem schmerz und diagnoseverfahren
ES2577011B1 (es) * 2015-01-09 2017-04-21 José Antonio FIZ FERNÁNDEZ Procedimiento para la lectura de la reacción de la tuberculina por toma de imágenes térmicas por infrarrojos
KR102192651B1 (ko) * 2017-08-23 2020-12-17 노을 주식회사 시약을 저장하는 저장 매체 및 이를 이용한 검사 방법 및 검사 모듈

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777130A (en) * 1984-12-05 1988-10-11 Andra Biologicals Isolation of mycobacterial a 60 antigen for diagnostic purposes
EP0199362A3 (de) * 1985-04-26 1987-10-07 Massachusetts Institute Of Technology System und Vorrichtung zur verzögerten und stossweisen Freisetzung biologisch aktiver Substanzen
JP2797308B2 (ja) 1988-03-25 1998-09-17 味の素株式会社 微生物セルロースの産生方法
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
JPH06169758A (ja) 1990-10-09 1994-06-21 Cosmo Sogo Kenkyusho:Kk 微生物及び５−アミノレブリン酸の製造方法
CA2121603A1 (en) * 1991-11-15 1993-05-16 Hirohisa Okuyama Antiphlogistic-analgesic plaster
DK79793D0 (da) 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
AU6260796A (en) * 1995-06-07 1996-12-30 National Jewish Center For Immunology And Respiratory Medicine Isolated formylated bacterial peptides, nucleic acid molecul es and uses thereof
JP3624389B2 (ja) 1996-01-30 2005-03-02 日本ビーシージー製造株式会社 Ｂｃｇ菌培養後の使用済み培養液より蛋白質を単離する方法
CN1194670C (zh) * 1998-02-06 2005-03-30 日本Bcg制造株式会社 用于传染病检测和诊断的方法和组合物

Also Published As

Publication number Publication date
CN1679928A (zh) 2005-10-12
JP4323600B2 (ja) 2009-09-02
CN1292688A (zh) 2001-04-25
EP1061905A2 (de) 2000-12-27
CA2319571A1 (en) 1999-08-12
DE69927794D1 (de) 2006-03-02
US20010043905A1 (en) 2001-11-22
WO1999039693A3 (en) 1999-09-23
CA2319571C (en) 2007-09-11
HK1035141A1 (en) 2001-11-16
US20050106107A1 (en) 2005-05-19
AU4480899A (en) 1999-08-23
CN100584378C (zh) 2010-01-27
WO1999039693A2 (en) 1999-08-12
US7655218B2 (en) 2010-02-02
US6979450B2 (en) 2005-12-27
EP1061905B1 (de) 2005-10-19
CN1194670C (zh) 2005-03-30
JPH11263736A (ja) 1999-09-28
HK1081437A1 (en) 2006-05-19
DE69927794T2 (de) 2006-07-13
US20100278742A1 (en) 2010-11-04
CN101804213A (zh) 2010-08-18

Similar Documents

Publication Publication Date Title
Friedman et al. Transmission of multidrug-resistant tuberculosis in a large urban setting.
CY1109531T1 (el) Πρωτεϊνες συντηξης του μυκοβακτηριδιου της φυματιωσης
HUP0203705A2 (hu) Vegyületek és eljárások Chlamydia-fertőzés kezelésére és diagnózisára
Moro et al. Effectiveness of infection control measures in controlling a nosocomial outbreak of multidrug-resistant tuberculosis among HIV patients in Italy
TR200002938T2 (tr) Mikrobakteri tüberküloz antijenlerinin füzyon proteinleri ve bunların kullanımı
DK1307564T3 (da) Forbindelser og fremgangsmåde til behandling og diagnose af chlamydiainfektion
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
HK1081437A1 (en) Use of mycobacterial antigen mpb64 in the manufacture of a product for topical detection of active tuberculosis
DE69628844D1 (de) Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose
ATE451477T1 (de) Diagnose und überwachung von hepatozellulärem karzinom
WO2006009838A3 (en) Mycobacterium tuberculosis epitopes and methods of use thereof
WO2002054073A3 (en) Latent human tuberculosis model, diagnostic antigens, and methods of use
EP0834567A3 (de) Zusammensetzungen und Verfahren zur Diagnose und Behandlung von Babesia microti Infektion
Maes Incidence of inapparent active mycobacterial infections in France detected by an IgG serological test based on antigen 60
Mokaddas et al. Molecular Fingerprinting of Isoniazid‐Resistant Mycobacterium tuberculosis Isolates from Chest Diseases Hospital in Kuwait
Kubin et al. Molecular epidemiology of tuberculosis in Prague: analysis by restriction fragment length polymorphism
Vijayalakshmi et al. Comparison of the immune responses in children vaccinated with three strains of BCG vaccine
WO1999061909A3 (en) Methods and compositions for the detection of human herpesvirus
Hak et al. Effectiveness of pneumococcal vaccine
Kaur et al. CUTANEOUS TB PROFILE IN NORTH WEST PUNJAB, INDIA: A RETROSPECTIVE DATA ANALYSIS.
TR200501240T3 (tr) Mycobacterium paratuberculosis suşları için dna test yönteminde ilerlemeler
Bhatki Case detection; are the present survey methods effective? A review of leprosy surveys in Bombay
AU756661C (en) Novel (poly)peptides which represent the epitopes of the human herpes virus type 8
EP1113073A3 (de) Leishmania Anitgene für Verwendung in Therapie und Diagnose von Leishmaniasis
Salamina et al. 418-PA10 1985–1994 Routine tuberculin testing among students in Italy

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
RZN Patent revoked